AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Alprostadil Cream treatment for female sexual arousal disorder to be presented.
2004 SEP 22 - (NewsRx.com & NewsRx.net) -- NexMed, Inc., (NASDAQ:NEXM) announced that it will present the new findings of a pilot clinical study conducted offshore, entitled "A Pilot Clinical Study of a Topical Alprostadil Cream for the Treatment of Female Sexual Arousal Disorder (FSAD)."
The presentation will take place at the Annual Meeting of the International Society for the Study of Women's Sexual Health on October 28-31, 2004, in Atlanta, Georgia. Femprox is NexMed's proprietary FSAD treatment under development and incorporates alprostadil (PGE) with the patented NexACT technology.
This was a randomized, placebo-controlled, double-blind, crossover clinical study that tested eight female patients, 21-45 years of age, diagnosed with FSAD (as defined by their sexual history, Female Sexual Distress Scale, and psychological assessment) for more than 6 months. The subjects received both a placebo cream and Femprox.
The primary efficacy end point was measured as the score of the arousal success or the number of the "Yes" responses to question 3 of the female sexual ...
- Alprostadil Cream treatment for female sexual arousal disorder to be presented.
- Newspaper article from: Biotech Business Week September 20, 2004 700+ words
...Clinical Study of a Topical Alprostadil Cream for the Treatment of Female Sexual Arousal Disorder (FSAD...their sexual history, Female Sexual Distress Scale, and...to question 3 of the female sexual encounter profile (FSEP...
- Promising Results Observed In Topical Alprostadil Cream Trial.
- Newspaper article from: Drug Week November 16, 2001 700+ words
...of Femprox (active ingredient alprostadil) in women with female sexual arousal disorder (FSAD) were encouraging. The study was...S. The study "Topical alprostadil in the treatment of female sexual arousal disorder," was published in the October-December...
- Promising Results Observed In Topical Alprostadil Cream Trial.(Brief Article)
- Magazine article from: Women's Health Weekly November 15, 2001 700+ words
...of Femprox (active ingredient alprostadil) in women with female sexual arousal disorder (FSAD) were encouraging. The study was...S. The study "Topical alprostadil in the treatment of female sexual arousal disorder," was published in the October-December...
- Data On Nexmed's Topical Alprostadil Cream Presented At the 8th World Meeting...
- Press release article from: Business Wire September 1, 1998 700+ words
...medical device company, is developing 1) Alprox-TD(TM) and Femprox(TM), topically-applied treatments for male and female sexual dysfunction; 2) Viratrol(R), a non-invasive, hand-held device for treating oral and genital herpes; 3) a generic...
- Research conducted at Q.P. Liao and co-authors has provided new information...
- Magazine article from: Women's Health Weekly September 4, 2008 700+ words
...treatment changes in Female Sexual Distress Scale. A total...and colleagues (see also Female Sexual Arousal Disorder). The...Efficacy and safety of alprostadil cream for the treatment of female sexual arousal disorder: A double...
- NexMed's Female Sexual Arousal Disorder Product Enters Phase 2 Clinical Trial.
- Press release article from: PR Newswire May 21, 2001 700+ words
...Femprox(TM), a topical treatment under development for female sexual arousal disorder ("FSAD"). The Phase 2 study is randomized...The Company is also developing Alprox-TD(R), an alprostadil cream treatment for ED, which was recently approved for sale...
- NexMed to Present Poster on Femprox at the American Urological Association...
- Press release article from: PR Newswire May 19, 2005 700+ words
...Findings Link the Use of Alprostadil Cream to Female Sexual Arousal Response - ROBBINSVILLE...poster entitled, "Effect of Alprostadil Cream on Cerebral Responses using...cream, for treatment of female sexual arousal disorder ('FSAD...
- NexMed Selected for Two Abstract and Two Podium Presentations During...
- Press release article from: PR Newswire March 27, 2003 700+ words
...A Novel Topical Alprostadil Cream for the Treatment...entitled "Treatment Of Female Sexual Arousal Disorder...Using A Novel Topical Alprostadil Cream: A Phase 2 Clinical...cream treatment for female sexual arousal disorder...